Rheumatoid arthritis: The two faces of Rsk2 in hyperplastic disease
Research output: Contribution to journal › Article
Colleges, School and Institutes
Given the established role of 90 kDa ribosomal S6 kinases (Rsk) in oncogenesis, and the promise of new Rsk-blocking cancer treatments, it is perhaps surprising that Rsk2-mediated inhibition of hyperplasia has now been demonstrated to occur in the arthritic synovium. Does this functional duality make Rsk2 a risky target for the treatment of rheumatoid arthritis?
|Number of pages||3|
|Journal||Nature Reviews Rheumatology|
|Early online date||27 Jan 2015|
|Publication status||Published - Apr 2015|